Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Buy
65
FMED Quote, Financials, Valuation and Earnings
Last price:
$23.84
Seasonality move
:
7.45%
Day range:
$23.74 - $23.85
52-week range:
$20.69 - $26.79
Dividend yield:
0.48%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.7K
Avg. volume:
8.3K
1-year change:
0.34%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Fidelity Disruptive Medicine ETF Number of Institutional Trades
Fidelity Disruptive Medicine ETF Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
--
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
--
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Fidelity Disruptive Medicine ETF Institutional Ownership
-
What Percentage Of FMED Is Owned by Institutions?
-- of FMED is owned by institutions.
-
How Many Institutions Own FMED Shares?
Fidelity Disruptive Medicine ETF stock is owned by 0 institutional shareholders at this time.
-
Have Institutions Been Buying FMED Stock?
Yes, institutions have bought 0 shares of FMED in the last quarter.
-
Have Institutions Been Selling FMED Stock?
Yes, institutions have sold 0 shares of FMED over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
52
CTRN alert for Jun 5
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 5
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
